Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway
- PMID: 16819628
- DOI: 10.1007/s00520-006-0097-7
Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway
Abstract
Introduction: Malnutrition is a common problem in cancer patients. Its incidence varies according to disease stage (between 15 and 90%) and is considered a possible prognostic factor for therapeutic response and survival. It is also one of the causes contributing to the increase in morbidity and mortality in patients. Tumor cachexia is defined as a nutritional defect caused by tumor growth in the patient and presents as a significant weight loss. This weight loss is mainly caused by a degradation of skeletal muscle proteins.
Conclusion: The ubiquitin-proteasome system is the most important pathway of protein degradation. As a regulatory system governing protein half-life, it is involved in the regulation of the cell cycle, signal transmission, immune system response, apoptosis, and oncogenesis. Knowledge of the molecular pathways involved in the induction of cancer-associated cachexia will favor a more rational approach to its treatment as well as possible quality of life and survival benefit for the patient.
Similar articles
-
Waste management - cytokines, growth factors and cachexia.Cytokine Growth Factor Rev. 2006 Dec;17(6):475-86. doi: 10.1016/j.cytogfr.2006.09.006. Epub 2006 Nov 22. Cytokine Growth Factor Rev. 2006. PMID: 17118696 Review.
-
Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome.Clin Cancer Res. 2007 Mar 1;13(5):1356-61. doi: 10.1158/1078-0432.CCR-06-2307. Clin Cancer Res. 2007. PMID: 17332276 Review.
-
Cytokines and cancer anorexia cachexia syndrome.Am J Hosp Palliat Care. 2008 Oct-Nov;25(5):407-11. doi: 10.1177/1049909108315518. Epub 2008 Apr 10. Am J Hosp Palliat Care. 2008. PMID: 18403577 Review.
-
The cancer anorexia/weight loss syndrome: therapeutic challenges.Curr Oncol Rep. 2005 Jul;7(4):271-6. doi: 10.1007/s11912-005-0050-9. Curr Oncol Rep. 2005. PMID: 15946586 Review.
-
[Recent development in research and management of cancer anorexia-cachexia syndrome].Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9. Gan To Kagaku Ryoho. 2005. PMID: 15984510 Review. Japanese.
Cited by
-
Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats.Mol Cell Biochem. 2015 Jan;399(1-2):237-46. doi: 10.1007/s11010-014-2250-9. Epub 2014 Oct 31. Mol Cell Biochem. 2015. PMID: 25359170
-
Hallmarks of Cancer Cachexia: Sexual Dimorphism in Related Pathways.Int J Mol Sci. 2025 Apr 22;26(9):3952. doi: 10.3390/ijms26093952. Int J Mol Sci. 2025. PMID: 40362192 Free PMC article. Review.
-
Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.BMC Cancer. 2009 Jul 28;9:255. doi: 10.1186/1471-2407-9-255. BMC Cancer. 2009. PMID: 19635171 Free PMC article.
-
Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune Score (mGRIm-s) as a clinico-immunological tool.J Cancer Res Clin Oncol. 2024 May 9;150(5):247. doi: 10.1007/s00432-024-05771-w. J Cancer Res Clin Oncol. 2024. PMID: 38722378 Free PMC article.
-
Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia.Eur J Transl Myol. 2018 Jun 6;28(2):7590. doi: 10.4081/ejtm.2018.7590. eCollection 2018 Apr 24. Eur J Transl Myol. 2018. PMID: 29991992 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials